{"id":6863,"date":"2013-05-28T01:59:25","date_gmt":"2013-05-28T05:59:25","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=6863"},"modified":"2013-05-28T01:59:25","modified_gmt":"2013-05-28T05:59:25","slug":"ziopharm-oncology-inc-nasdaqziop-shares-increasing-rapidly-by-29-75","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/ziopharm-oncology-inc-nasdaqziop-shares-increasing-rapidly-by-29-75-6863","title":{"rendered":"ZIOPHARM Oncology Inc (NASDAQ:ZIOP) shares increasing rapidly by 29.75%"},"content":{"rendered":"<p style=\"text-align: justify;\">Boston, MA 05\/28\/2013 (wallstreetpr) &#8211;\u00a0In Friday\u2019s trading session, ZIOPHARM Oncology Inc (NASDAQ:ZIOP) rose by 29.75%. It opened at $2.10 per share, touched an intraday high of $2.96 and dropped down to close at $2.08 per share. More than 16.77 million shares were traded in Friday\u2019s trading session. This number stood above the average volume of 1.46 million that was measured over a 30-day period.<\/p>\n<p style=\"text-align: justify;\">Very\u00a0 recently, ZIOPHARM Oncology Inc (NASDAQ:ZIOP) announced that Jonathan Lewis, CEO, is scheduled to present at the 38<sup>th<\/sup>\u00a0Annual Deutsche Bank Health Care Conference that is to be held on 29 May 2013. This increased activity has boosted ZIOPHARM Oncology Inc (NASDAQ:ZIOP) into overbought territory. The company stock now has a 72.54 RSI. At current market valuation ZIOP has risen 33.91% on the SMA20 and 0.94 on the SMA50. The company\u2019s technical chart shows that there has been a slight uptrend from the comparatively flat trading which prevailed since the beginning of May 2013. On an average, analysts have set a 2.88 target price for the stock.<\/p>\n<p style=\"text-align: justify;\">ZIOPHARM Oncology Inc (NASDAQ:ZIOP) is a bio-pharma company. It is focused on discovering and developing new cancer therapies. It is applying its technologies for cancer research to develop various therapeutics for patients. ZOIP\u2019s portfolio is made up of five different clinical-stage product candidates and multiple research-stage candidates. ZIOPHARM Oncology Inc (NASDAQ:ZIOP)\u2019s clinical programs include IL-12 DNA, palifosfamide (ZIO-201), darinaparsin (ZIO-101) and indibulin (ZIO-301).\u00a0 Palifosfamide is a deoxyribonucleic acid -targeted cancer treatment. It bypasses drug-resistance that has been mediated by aldehyde dehydrogenase.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Boston, MA 05\/28\/2013 (wallstreetpr) &#8211;\u00a0In Friday\u2019s trading session, ZIOPHARM Oncology Inc (NASDAQ:ZIOP) rose by 29.75%. It opened at $2.10 per share, touched an intraday high [&hellip;]<\/p>\n","protected":false},"author":15,"featured_media":6864,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[2269,2268],"stock_ticker":[],"class_list":["post-6863","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-nasdaqziop","tag-ziopharm-oncology-inc-nasdaqziop","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ZIOPHARM Oncology Inc (NASDAQ:ZIOP) shares increasing rapidly by 29.75% - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/ziopharm-oncology-inc-nasdaqziop-shares-increasing-rapidly-by-29-75-6863\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ZIOPHARM Oncology Inc (NASDAQ:ZIOP) shares increasing rapidly by 29.75% - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Boston, MA 05\/28\/2013 (wallstreetpr) &#8211;\u00a0In Friday\u2019s trading session, ZIOPHARM Oncology Inc (NASDAQ:ZIOP) rose by 29.75%. It opened at $2.10 per share, touched an intraday high [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/ziopharm-oncology-inc-nasdaqziop-shares-increasing-rapidly-by-29-75-6863\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2013-05-28T05:59:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/05\/1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"768\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Benjamin Roussey\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Benjamin Roussey\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/ziopharm-oncology-inc-nasdaqziop-shares-increasing-rapidly-by-29-75-6863#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/ziopharm-oncology-inc-nasdaqziop-shares-increasing-rapidly-by-29-75-6863\"},\"author\":{\"name\":\"Benjamin Roussey\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e82d48e74e653b113f0f9186826f808d\"},\"headline\":\"ZIOPHARM Oncology Inc (NASDAQ:ZIOP) shares increasing rapidly by 29.75%\",\"datePublished\":\"2013-05-28T05:59:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/ziopharm-oncology-inc-nasdaqziop-shares-increasing-rapidly-by-29-75-6863\"},\"wordCount\":258,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/ziopharm-oncology-inc-nasdaqziop-shares-increasing-rapidly-by-29-75-6863#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/05\/1.jpg\",\"keywords\":[\"NASDAQ:ZIOP\",\"Ziopharm Oncology Inc. (NASDAQ:ZIOP)\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/ziopharm-oncology-inc-nasdaqziop-shares-increasing-rapidly-by-29-75-6863#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/ziopharm-oncology-inc-nasdaqziop-shares-increasing-rapidly-by-29-75-6863\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/ziopharm-oncology-inc-nasdaqziop-shares-increasing-rapidly-by-29-75-6863\",\"name\":\"ZIOPHARM Oncology Inc (NASDAQ:ZIOP) shares increasing rapidly by 29.75% - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/ziopharm-oncology-inc-nasdaqziop-shares-increasing-rapidly-by-29-75-6863#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/ziopharm-oncology-inc-nasdaqziop-shares-increasing-rapidly-by-29-75-6863#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/05\/1.jpg\",\"datePublished\":\"2013-05-28T05:59:25+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/ziopharm-oncology-inc-nasdaqziop-shares-increasing-rapidly-by-29-75-6863#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/ziopharm-oncology-inc-nasdaqziop-shares-increasing-rapidly-by-29-75-6863\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/ziopharm-oncology-inc-nasdaqziop-shares-increasing-rapidly-by-29-75-6863#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/05\/1.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/05\/1.jpg\",\"width\":1024,\"height\":768},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/ziopharm-oncology-inc-nasdaqziop-shares-increasing-rapidly-by-29-75-6863#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ZIOPHARM Oncology Inc (NASDAQ:ZIOP) shares increasing rapidly by 29.75%\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e82d48e74e653b113f0f9186826f808d\",\"name\":\"Benjamin Roussey\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e051c9045b5c74768cca8f069d353d6ff45d41d241616ca1151ef20f3f86ff14?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e051c9045b5c74768cca8f069d353d6ff45d41d241616ca1151ef20f3f86ff14?s=96&d=mm&r=g\",\"caption\":\"Benjamin Roussey\"},\"description\":\"Benjamin Roussey is from Sacramento, California. He has two master\u2019s degrees and served four years in the U.S. Navy. His bachelor\u2019s degree is from CSUS (1999) where he was on a baseball pitching scholarship. His second master\u2019s degree is an MBA in Global Management from the University of Phoenix (2006). He has worked for small businesses, public agencies, and large corporations. He has lived in Korea and Saudi Arabia where he was an ESL instructor. Benjamin spends his time in between Northern California and Cabo San Lucas, Mexico, committing himself to his craft of freelance and website writing. http:\/\/www.facebook.com\/ben.rouss\",\"sameAs\":[\"https:\/\/cablemanpro.com\/wallstreetpr\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/benjamin-roussey\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ZIOPHARM Oncology Inc (NASDAQ:ZIOP) shares increasing rapidly by 29.75% - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/ziopharm-oncology-inc-nasdaqziop-shares-increasing-rapidly-by-29-75-6863","og_locale":"en_US","og_type":"article","og_title":"ZIOPHARM Oncology Inc (NASDAQ:ZIOP) shares increasing rapidly by 29.75% - Wall Street PR","og_description":"Boston, MA 05\/28\/2013 (wallstreetpr) &#8211;\u00a0In Friday\u2019s trading session, ZIOPHARM Oncology Inc (NASDAQ:ZIOP) rose by 29.75%. It opened at $2.10 per share, touched an intraday high [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/ziopharm-oncology-inc-nasdaqziop-shares-increasing-rapidly-by-29-75-6863","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2013-05-28T05:59:25+00:00","og_image":[{"width":1024,"height":768,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/05\/1.jpg","type":"image\/jpeg"}],"author":"Benjamin Roussey","twitter_misc":{"Written by":"Benjamin Roussey","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/ziopharm-oncology-inc-nasdaqziop-shares-increasing-rapidly-by-29-75-6863#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/ziopharm-oncology-inc-nasdaqziop-shares-increasing-rapidly-by-29-75-6863"},"author":{"name":"Benjamin Roussey","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e82d48e74e653b113f0f9186826f808d"},"headline":"ZIOPHARM Oncology Inc (NASDAQ:ZIOP) shares increasing rapidly by 29.75%","datePublished":"2013-05-28T05:59:25+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/ziopharm-oncology-inc-nasdaqziop-shares-increasing-rapidly-by-29-75-6863"},"wordCount":258,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/ziopharm-oncology-inc-nasdaqziop-shares-increasing-rapidly-by-29-75-6863#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/05\/1.jpg","keywords":["NASDAQ:ZIOP","Ziopharm Oncology Inc. (NASDAQ:ZIOP)"],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/ziopharm-oncology-inc-nasdaqziop-shares-increasing-rapidly-by-29-75-6863#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/ziopharm-oncology-inc-nasdaqziop-shares-increasing-rapidly-by-29-75-6863","url":"https:\/\/cablemanpro.com\/wallstreetpr\/ziopharm-oncology-inc-nasdaqziop-shares-increasing-rapidly-by-29-75-6863","name":"ZIOPHARM Oncology Inc (NASDAQ:ZIOP) shares increasing rapidly by 29.75% - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/ziopharm-oncology-inc-nasdaqziop-shares-increasing-rapidly-by-29-75-6863#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/ziopharm-oncology-inc-nasdaqziop-shares-increasing-rapidly-by-29-75-6863#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/05\/1.jpg","datePublished":"2013-05-28T05:59:25+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/ziopharm-oncology-inc-nasdaqziop-shares-increasing-rapidly-by-29-75-6863#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/ziopharm-oncology-inc-nasdaqziop-shares-increasing-rapidly-by-29-75-6863"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/ziopharm-oncology-inc-nasdaqziop-shares-increasing-rapidly-by-29-75-6863#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/05\/1.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/05\/1.jpg","width":1024,"height":768},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/ziopharm-oncology-inc-nasdaqziop-shares-increasing-rapidly-by-29-75-6863#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"ZIOPHARM Oncology Inc (NASDAQ:ZIOP) shares increasing rapidly by 29.75%"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e82d48e74e653b113f0f9186826f808d","name":"Benjamin Roussey","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/e051c9045b5c74768cca8f069d353d6ff45d41d241616ca1151ef20f3f86ff14?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e051c9045b5c74768cca8f069d353d6ff45d41d241616ca1151ef20f3f86ff14?s=96&d=mm&r=g","caption":"Benjamin Roussey"},"description":"Benjamin Roussey is from Sacramento, California. He has two master\u2019s degrees and served four years in the U.S. Navy. His bachelor\u2019s degree is from CSUS (1999) where he was on a baseball pitching scholarship. His second master\u2019s degree is an MBA in Global Management from the University of Phoenix (2006). He has worked for small businesses, public agencies, and large corporations. He has lived in Korea and Saudi Arabia where he was an ESL instructor. Benjamin spends his time in between Northern California and Cabo San Lucas, Mexico, committing himself to his craft of freelance and website writing. http:\/\/www.facebook.com\/ben.rouss","sameAs":["https:\/\/cablemanpro.com\/wallstreetpr"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/benjamin-roussey"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/6863","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/15"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=6863"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/6863\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/6864"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=6863"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=6863"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=6863"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=6863"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}